Biostax Corp.
BTAX
$0.01
$0.00111.11%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -443.50K | -337.10K | -1.05M | -388.80K | -504.20K |
| Total Depreciation and Amortization | -- | -- | 13.80K | 13.80K | 13.40K |
| Total Amortization of Deferred Charges | -- | -- | 10.30K | -- | -- |
| Total Other Non-Cash Items | 107.90K | -- | 701.80K | 40.00K | 150.00K |
| Change in Net Operating Assets | 354.00K | 283.20K | 488.10K | 346.00K | 26.80K |
| Cash from Operations | 18.40K | -53.80K | 160.40K | 11.10K | -314.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -20.50K | 26.20K | -135.00K | -24.00K | 296.50K |
| Total Debt Repaid | -- | -- | -200.00 | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -20.50K | 26.20K | -135.20K | -24.00K | 296.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | -- | 0.00 | 0.00 |
| Net Change in Cash | -2.10K | -27.70K | 25.30K | -12.90K | -17.60K |
